Stay updated with breaking news from Final Decision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. Food and Drug Administration FDA announced decision to withdraw approval of Makena® hydroxyprogesterone caproate injection, drug approved in 2011 to reduce risk of preterm birth in certain pregnant women.
On April 5, 2023, the U.S. Food and Drug Administration (“FDA”) announced its decision to withdraw the approval of Makena® hydroxyprogesterone caproate injection (“Makena”) – a drug...
Tax Notes: Clarification on certain policies on filing of appeal against FDDA
STA speaking up on Green Ridge To the Editor: The relationship between wildfires in the West and responsible forest management is a highly debated
Another huge change in plans for Impact Wrestling...